Treatment successfully delivers drug across the blood-brain barrier directly to brain tumor in mice
- Glioblastoma currently has no cure. New treatments urgently needed
- Powerful drug is 1,400 times more potent than current treatment against the brain tumor
- Scientists applying to FDA for approval to test this novel treatment in patients with recurrent glioblastoma
One of most potent drugs for treatment of glioblastoma, the most deadly type of brain tumor, can’t be used in patients because of two problems. First, it can’t reach its target because it’s blocked by the blood-brain barrier, a microscopic structure that protects the brain from toxins in the blood. And the conventional formulation for this drug is toxic to the brain.
But now Northwestern Medicine scientists have used a novel technology for opening the blood-brain barrier with an implantable ultrasound, and have delivered the powerful drug to the tumor in mice. In a new paper, they report on their findings of extensive preclinical research.
The scientists also discovered brain toxicity for the conventional formulation for this drug – paclitaxel -to the brain was caused by the solution required to dissolve the drug (cremophor.) Scientists tested a new formulation of the drug that uses albumin as opposed to cremophor, and it was not harmful to the brain.
Opening of the blood-brain barrier with an ultrasound increased the concentrations of this paclitaxel in the brain by five-fold. The study also showed that the brain tumor-bearing mice live much longer when treated with the powerful cancer-fighting drug paclitaxel, and survival was even further extended when treated in combination with ultrasound to open the blood-brain barrier.
The study will be published Dec. 12 in Clinical Cancer Research, a journal of the American Association for Cancer Research.
In the laboratory, paclitaxel is much more potent than the currently used chemotherapy temozolomide. When paclitaxel was tested against the brain tumor in a dish outside an organism, a 1,400-fold lesser drug concentration was necessary to kill same number of tumor cells, compared to the conventional chemotherapy used for this cancer.
The scientists are now applying to the U.S. Food & Drug Administration to launch a clinical trial to test this concept of a new formulation of paclitaxel in combination with the novel ultrasound technology to open the blood-brain barrier in patients. The planned trial aims to determine if the treatment is safe, and if it prolongs survival of patients with brain cancer.
“Glioblastoma currently has no cure, and when the tumor recurs there are not many treatment options,” said the principal investigator for this study, Dr. Adam Sonabend, an assistant professor of neurological surgery at Northwestern University Feinberg School of Medicine and a Northwestern Medicine physician. “We urgently need effective new treatments.”
The ultrasound technology may have broader benefits. “This ultrasound technology now will enable us to use many agents established in other cancers for patients with brain tumors,” said co-investigator Roger Stupp, chief of neuro-oncology and the Paul C. Bucy Professor of Neurological Surgery at Feinberg.
Other clinical trials are testing ultrasound-based opening of the blood brain barrier with various chemotherapy agents, but none are using such a potent drug as paclitaxel.
How does it work?
The tiny ultrasound would be implanted during surgery into a window in the skull that does not contain bone. It is used in combination with microscopic gas bubbles injected into the blood at the same time the ultrasound begins. When the bubbles hit the sound waves, these vibrate and mechanically disrupt the blood-brain barrier. The opening is immediate, allowing penetration of the drug molecules. The blood-brain barrier opening is reversible and lasts for several hours after the sonication. The ultrasound emitter remains in the skull for repeated delivery of the drug.
Go deeper with Bing News on:
- miR-548x and miR-4698 controlled cell proliferation by affecting the PI3K/AKT signaling pathway in Glioblastoma cell lineson January 31, 2020 at 2:54 am
Glioblastoma multiforme (GBM) is the most aggressive and prevalent form of brain tumor cancers that originate from glial cells. This study proposed to investigate the effect of miR-548x and miR-4698 ...
- The Importance of Combination Immune Therapy in Orthotopic Murine Glioblastomaon January 30, 2020 at 8:07 pm
Connor Liu, medical student, Washington University School of Medicine, discusses the importance of combination immunotherapy in orthotopic murine glioblastoma. With a historically aggressive and ...
- RBL1 (p107) functions as tumor suppressor in glioblastoma and small-cell pancreatic neuroendocrine carcinoma in Xenopus tropicalison January 30, 2020 at 9:43 am
Cancer Cell. 2015;27:712–27. McLendon R, Friedman A, Bigner D, Van Meir EG, Brat DJ, Mastrogianakis GM, et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways ...
- Glioblastoma Alters Synaptic Function to Promote Tumor Growthon January 30, 2020 at 5:28 am
Scientists at Baylor College of Medicine report on studies in mice, which indicate that glioblastoma brain tumors impact on the activity of neighboring neurons, promoting a vicious cycle that alters ...
- Brain organoids reveal glioblastoma originson January 29, 2020 at 4:55 am
They discovered that glioblastomas do not appear to originate from a single cell type—what other researchers have called a "glioblastoma stem cell"—but instead arise from multiple kinds of seed cells, ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Job of the Week: PhD scholarship in GPU processing for Super Resolution Ultrasound Imagingon February 1, 2020 at 7:39 am
The Technical University of Denmark (DTU) is seeking a in our PhD scholarship in GPU processing for Super Resolution Ultrasound Imaging in our Job of the Week. A 3-year PhD scholarship is available at ...
- Ultrasound Probe Disinfection Market Revenue and Gross Margin by 2029 | Nanosonics, Civco Medical Solutions and Tristelon January 31, 2020 at 3:47 am
The continuing growth story of Ultrasound Probe Disinfection Market report consisting of important parts, which present many aspects of the worldwide market with provides more accurate and meaningful ...
- Nikki Bella Shares Her Ultrasound Photo After Announcing She And Sister Brie Are Both Expectingon January 30, 2020 at 8:12 am
Nikki Bella and her twin sister Brie made the surprising announcement on Wednesday that they're both pregnant, and they're due dates are just two weeks apart. Shortly after the big news was published ...
- The global animal/veterinary ultrasound market size is projected to reach USD 448 million by 2025 from USD 338 million in 2020, at a CAGR of 5.8%on January 30, 2020 at 6:20 am
/PRNewswire/ -- The global animal/veterinary ultrasound market size is projected to reach USD 448 million by 2025 from USD 338 million in 2020, at a CAGR ...
- Watch This Amazing Ultrasound Of A Baby Tiger Sharkon January 30, 2020 at 6:00 am
Together, they have been studying the abundance of pregnant tiger sharks in the bay via ultrasound scanning, blood sampling for hormone analysis, and tagging for further tracking of the pregnant ...